Published in J Proteomics on May 02, 2009
Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations. Proteomics (2010) 0.99
Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C). Prion (2010) 0.86
Na+/K+-ATPase is present in scrapie-associated fibrils, modulates PrP misfolding in vitro and links PrP function and dysfunction. PLoS One (2011) 0.78
Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake. J Virol (2015) 0.78
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J (1987) 1.64
Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (1995) 1.46
Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases. J Mol Biol (2000) 1.41
Western blot detection of PrP(Sc)in Cyprus sheep with natural scrapie. Vet J (2000) 1.40
Astrocyte gene expression in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (1987) 1.37
The crystal structures of the complexes between bovine beta-trypsin and ten P1 variants of BPTI. J Mol Biol (1999) 1.28
Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease. Nucleic Acids Res (1994) 1.17
Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie. Proc Natl Acad Sci U S A (1986) 1.15
Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases. J Mol Biol (1999) 1.12
Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations. Microb Pathog (1990) 1.11
Structure-function relationship of serine protease-protein inhibitor interaction. Acta Biochim Pol (2001) 1.05
Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases. Acta Neuropathol (2001) 0.96
CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol (2007) 0.95
Conformational study of two synthetic peptides with sequence analogies to the N-terminal fragment of RNase A. Biophys Chem (1986) 0.94
Lichtenstein inguinal hernia repair in a primary healthcare setting. Br J Surg (1998) 0.92
Selection of potent chymotrypsin and elastase inhibitors from M13 phage library of basic pancreatic trypsin inhibitor (BPTI). Biochim Biophys Acta (2001) 0.91
Proteinase K-resistant material in ARR/VRQ sheep brain affected with classical scrapie is composed mainly of VRQ prion protein. J Virol (2011) 0.90
Inhibition of six serine proteinases of the human coagulation system by mutants of bovine pancreatic trypsin inhibitor. J Biol Chem (2000) 0.89
Potential retroviral RNAs in Creutzfeldt-Jakob disease. J Virol (1990) 0.88
Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population. Ann Neurol (2001) 0.86
Specificity of human cathepsin G. Biochim Biophys Acta (1998) 0.86
Fluorescence studies on association of human translation initiation factor eIF4E with mRNA cap-analogues. Z Naturforsch C (1999) 0.85
Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin. J Mol Biol (1998) 0.85
Photocatalytic degradation of prions using the photo-Fenton reagent. J Hosp Infect (2008) 0.84
Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract. Eur J Neurosci (2008) 0.83
Stability of the residual structure in unfolded BPTI in different conditions of temperature and solvent composition measured by disulphide kinetics and double mutant cycle analysis. J Mol Biol (1999) 0.81
Photocatalytic degradation and drug activity reduction of Chloramphenicol. Water Res (2007) 0.79
Antigenic profile of human recombinant PrP: generation and characterization of a versatile polyclonal antiserum. J Neuroimmunol (2004) 0.79
Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies. Neurobiol Dis (2005) 0.79
Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction. Age (Dordr) (2013) 0.79
Expression of the prion protein in the rat forebrain--an immunohistochemical study. Neurosci Lett (1999) 0.78
Glycosaminoglycan analysis in brain stems from animals infected with the bovine spongiform encephalopathy agent. Arch Biochem Biophys (1999) 0.78
Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates. Anal Biochem (2006) 0.78
A survey of more than 11 years of neurologic diseases of ruminants with special reference to transmissible spongiform encephalopathies (TSEs) in Greece. J Vet Med B Infect Dis Vet Public Health (2000) 0.77
Atomic force microscopy to characterize the molecular size of prion protein. J Microsc (2008) 0.76
How to switch the motor on: RNA polymerase initiation steps at the single-molecule level. Protein Sci (2017) 0.75
[The results of determining the mental level and the EEG in 6 children from 3.5 to 12.5 years of age following acrodynia]. Wiad Lek (1970) 0.75
Genotyping for PrP gene polymorphisms in rare Greek breeds of sheep. Vet Rec (2007) 0.75
Metabolite levels and activities of some enzymes of carbohydrate metabolism in tissues of conventional and mono-associated mice in the course of Trichinella spiralis infection. Bull Acad Pol Sci Biol (1978) 0.75
[Effect of tetracycline on the level of nicotinamide and adenine nucleotides and of flavins in piglet's tissues]. Pol Arch Weter (1972) 0.75
[Results of screening tests for gestational diabetes mellitus at Medical University in Warsaw]. Ginekol Pol (1999) 0.75
The effect of duration of pregnancy on the activity of cystine aminopeptidase (CAP) isoenzymes in biological fluids and tissues of sows and their fetuses. Zentralbl Veterinarmed A (1987) 0.75
[Risk factors for gestational diabetes mellitus and results of glucose tolerance tests]. Ginekol Pol (1999) 0.75
[Activity of the Krebs cycle dehydrogenases, phosphatases and tryptophan pyrrolase in tissues of piglets treated with tetracycline]. Acta Physiol Pol (1972) 0.75
[Activity of various enzymes in the blood, liver, intestines and kidneys in spontaneous colibacteriosis of piglets]. Pol Arch Weter (1979) 0.75
[Effect of malathion on the nucleolytic enzyme activity of lymphocytes]. Folia Med Cracov (1987) 0.75
[Oxidation-reduction reactions in calves with E. coli infections]. Acta Physiol Pol (1972) 0.75
[P1 blood group, secretion status and susceptibility to asymptomatic bacteriuria in diabetes]. Pol Arch Med Wewn (1994) 0.75
Minerals and colibacteriosis in calves. Acta Microbiol Pol B (1974) 0.75
The effect of malathion on RNA polymerase activity of cell nuclei and transcription products in lymphocyte culture. Environ Res (1986) 0.75
Distribution of iron in pig placenta (Sus scrofa dom. L.). Folia Histochem Cytobiol (1987) 0.75
Metabolite levels and activities of some enzymes of carbohydrate metabolism in livers and intestines of conventional and bi-associated (with Staphylococcus epidermidis and Escherichia coli) mice in the course of Trichinella spiralis infection. Bull Acad Pol Sci Biol (1977) 0.75
High-energy phosphate level and cytochrome c linked enzymes activity in some internal organs of sheep with lower phagocytic activity of the reticulo-endothelial system. J Comp Pathol (1967) 0.75
Phage display selection of P1 mutants of BPTI directed against five different serine proteinases. Biol Chem (1999) 0.75